‘Biovail Corp. has won Canadian approval for the use of once-daily tablets of Wellbutrin XL to treat major depression in adults.

Therapeutic Products Directorate Canada issued a notice of compliance for 150-milligram and 300-milligram tablet strengths of Wellbutrin XL, an extended-release formulation of bupropion hydrochloride.’

Read more at Biovail depression drug okayed

Recent Entries

• One in five won’t work with depressed
• Hispanics have different depression rates
• Tai chi to help farmers fight depression
• Positive experiences ease MS depression
• Depression and Alzheimer’s Linked
• Insomnia may boost future depression risk
• Depression After Stroke Can Be Debilitating
• Antismoking Pill May Ease Depression … Or Cause Suicidal Thoughts
• Seasonal allergies could spark depression, fatigue
• Depression After a Heart Attack Dangerous for Years

This entry was posted on Thursday, January 19th, 2006 at 12:40 pm and is filed under Antidepressant. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.